Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-15 Sale | 2021-03-16 7:45 pm | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 22,912 | $6.9151 | $158,440 | 122,746 (Direct) | View |
| 2019-08-02 Purchase | 2019-08-02 4:15 pm | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 10,000 | $1.14 | $11,400 | 43,368 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-15 Exercise | 2021-03-16 7:45 pm | N/A 2030-02-06 | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 12,000 | $0 | 122,746 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-16 7:45 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 12,000 | $3.31 | 122,746 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 5:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 10,765 | $7.19 | 119,508 (Direct) | View |
| 2021-02-28 Exercise | 2021-03-02 5:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 28,316 | $0 | 119,508 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 40,570 | $0 | 40,570 (Direct) | View |
| 2020-04-22 Tax Withholding | 2020-04-24 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 3,997 | $1.96 | 65,127 (Direct) | View |
| 2020-04-22 Option Award | 2020-04-24 5:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 13,262 | $0 | 65,127 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 3,902 | $2.77 | 79,018 (Direct) | View |
| 2020-02-28 Exercise | 2020-03-03 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 16,396 | $0 | 79,018 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting | 104,970 | $0 | 104,970 (Direct) | View |